Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

AAPL
Is Siyata Mobile Walkie-ing The Talk-ie? Connecting People Around The World Via Next-Gen Mission-Critical Devices

Is Siyata Mobile Walkie-ing The Talk-ie? Connecting People Around The World Via Next-Gen Mission-Critical Devices...

Medunik
FDA Approves PHEBURANE — Medunik USA

Medunik USA announced the FDA approval of Pheburane (sodium phenylbutyrate) for the off-label treatment of urea cycle disorders, aiming to expand a li...

AbbVie
FDA Approves SKYRIZI — AbbVie Inc.

AbbVie announced the FDA approval of risankizumab-RZAA (Skyrizi) for intravenous use, a formulation that may broaden the biologic’s market presence al...

SYTA
Are New Communication Products Like The SD7 Poised To Give A Significant Boost To The Push-To-Talk Market?

Are New Communication Products Like The SD7 Poised To Give A Significant Boost To The Push-To-Talk Market?...

Camber
FDA Approves NAPROXEN — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals, Inc. announced late Monday the approval of its Abbreviated New Drug Application, No. ANDA215776, for the oral formulation of N...

Eugia
FDA Approves LEUPROLIDE ACETATE — Eugia US LLC

# FDA Approves Eugia US LLC's Generic Leuprolide Acetate Eugia US LLC received FDA approval for its generic leuprolide acetate formulation, marking a...

United
FDA Approves TYVASO DPI — United Therapeutics Corporation

United Therapeutics Corporation announced on May 23, 2022, the FDA approval of the oral form of Treprostinil (TYVASO DPI), a strategic move to broaden...

Alvogen
FDA Approves BUPRENORPHINE TRANSDERMAL SYSTEM — Alvogen Inc.

Alvogen Inc. announced May 17 the FDA approval of its ANDA for transdermal buprenorphine, offering a generic alternative to the branded product. The a...

Eli
FDA Approves MOUNJARO — Eli Lilly and Company

The FDA has granted full approval to Mounjaro (tirzepatide), Eli Lilly’s once-weekly injectable twincretin agonist, for the treatment of type 2 diabet...

Aurobindo
FDA Approves VIGABATRIN — Aurobindo Pharma Limited

# FDA Approves Aurobindo Pharma's Generic Vigabatrin, Expanding Treatment Options for Seizure Disorders The FDA has approved Aurobindo Pharma Limited...

Teva
FDA Approves POMALIDOMIDE — Teva Pharmaceuticals, Inc.

# FDA Approves Generic Version of Pomalidomide; Teva Gains Market Entry Teva Pharmaceuticals, Inc. received FDA approval for its generic oral pomalid...

LUPIN
FDA Approves Unknown Drug — LUPIN LTD

# FDA Approves Lupin Ltd's Generic Drug Application Lupin Ltd has received FDA approval for generic drug application ANDA091040, expanding the compan...

BRISTOL
FDA Approves Unknown Drug — BRISTOL

On April 28, 2022, Bristol Myers Squibb announced the FDA approval of the specified NDA, a move that is expected to bolster its commercial portfolio a...

ADAPTIS
FDA Approves Unknown Drug — ADAPTIS

On April 19, 2022, ADAPTIS received FDA approval for ANDA213796, granting the company rights to manufacture a generic version of an undisclosed substa...

Solco
FDA Approves NEBIVOLOL — Solco Healthcare US, LLC

# FDA Approves Generic Nebivolol; Solco Healthcare Entry Expected to Intensify Competition in Beta-Blocker Market Solco Healthcare US, LLC received F...

Novartis
FDA Approves PLUVICTO — Novartis Pharmaceuticals Corporation

# FDA Approves Novartis's PLUVICTO for Prostate Cancer Treatment Novartis Pharmaceuticals Corporation received FDA approval for PLUVICTO (lutetium lu...

NOVEN
FDA Approves Unknown Drug — NOVEN PHARMS INC

Noon Pharmaceuticals Inc. received FDA approval for a new agent on March 22, according to market intelligence sources. The company anticipates a signi...

MSN
FDA Approves LACOSAMIDE — MSN LABORATORIES PRIVATE LIMITED

MSN LABORATORIES PRIVATE LIMITED has received approval for its ANDA 204921 for lacosamide, enabling the launch of the generic version of the oral drug...

Amneal
FDA Approves LACOSAMIDE — Amneal Pharmaceuticals of New York LLC

On March 17, 2022, Amneal Pharmaceuticals of New York LLC received FDA approval for its Abbreviated New Drug Application (ANDA) #204857 for the generi...

Mylan
FDA Approves METHYLPHENIDATE — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc. has secured FDA approval for its ANDA206497, granting market access to the transdermal form of methylphenidate, a critical ...